Global access to health

Empresa

Descubrimiento de fármacos

Dirección: Avenida del Desarrollo Tecnologico, n 11
Ciudad: Jerez de la Frontera
País: España
Telf.: 34 856 818 424
Fax: 34 956 876 851
internet@bionaturis.es
http://www.bionaturis.es

Bionaturis is a public-owned biopharmaceutical company, founded in 2005 in Cadiz, developing and producing biomedical products for the pharmaceutical and veterinarian sectors.

Bionaturis was established in 2005, in the academic environment of the University of Cadiz, and strengthened its strategic presence by locating its research laboratory, development and innovation (R&D+I) in the Centro Andaluz de Biologia de Desarrollo (CABD) University Pablo de Olavide (Seville).Bionaturis counted with the support of the venture company Univen Capital in its development phase, as well as the contributions of the national and regional governments.
Faced with a pharmaceutical sector that finds itself in a restructuring process, Bionaturis is presented as a real alternative to lead new market opportunities, while offering new hope to millions of patients worldwide with currently no effective treatment.To hit these new markets, Bionaturis shows a new concept in the development of biopharamaceuticals, called FLYLIFE®.
Bionaturis has chosen Nature as an optimized source for the production of biopharmaceuticals, substituting the traditional industrial cumbersome steel reactors for single use, disposable and naturally occurring individual reactors.
FLYLIFE® makes use of natural resources to achieve and indeed surpass the productive capacity of traditional industry standards but utilizing up to ten-fold less space and fifteen-fold less investment. Amongst others, in niche markets where currently there is no solution, these competitive advantages provide a profitable solution and gives renewed hope to millions of worldwide patients.
With this new manufacturing concept, Bionaturis perfectly adapts to new trends that are reshaping the pharmaceutical and veterinary sectors, and thus completing its mission to lead the alternative systems of production of biological drugs.